George W. LeMaitre, Chairman and CEO at LEMAITRE VASCULAR INC (LMAT), sold 157,588 shares at $76.42 ($11.8M) on 2024-05-13, disclosed to the SEC on 2024-05-15.
Scheduled sale ($11.8M) by Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.42 | 35,826 | $2.7M | 23.3% |
| 2 | $76.42 | 35,826 | $2.7M | 23.3% |
| 3 | $0.00 | 4,000 | $0 | 0.0% |
| 4 | $76.80 | 40,968 | $3.1M | 26.7% |
| 5 | $76.80 | 40,968 | $3.1M | 26.7% |
| Total | $74.68 avg | 157,588 |
| $11.8M |
| 100% |
| Filing → |
| LMAT | SELL | 2025-08-08 | $9.4M | — | Filing → |
| LMAT | SELL | 2025-05-20 | $16.3M | — | Filing → |
| LMAT | SELL | 2024-07-18 | $9.9M | — | Filing → |